3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA"

Transcription

1 3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA Uncovering the Future of Formulation Development, Oral Drug Delivery and Innovative Strategies to Accelerate Drug Product Time-To-Market In today s high-risk, overcrowded and highly regulated drug development marketplace, we understand the drug development industry is in critical need of innovative formulation approaches and methodologies in order to get new approved oral drug products to market in a timely fashion. The 3rd Annual Oral Drug Formulation Innovations Summit will showcase the industry s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. Learn directly from leading global formulation experts in both industry and academia on how to effectively develop poorly soluble drugs into scientifically unique, compliant, patient-centric formulations. Additionally, learn innovative strategies to significantly reduce product development timelines, brush up on the latest regulatory requirements and learn multiple innovative strategies to optimize and enhance your product portfolio. Breakthrough innovations in the next generation of drug products: A new thinking for formulation design Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies Beyond the pill: Addressing future patient needs through the importance of pharmaceutical profiling Understanding and establishing the right conditions for IVIVC correlation Utilizing nanoparticles for the development of the next generation of drug products Effective formulation development strategies for improving oral bioavailability of poorly water-soluble drugs Characterization of amorphous materials to advance product development Spray-dried dispersion formulations in suspensions and solid dosage forms Combining In-Vivo animal models with physiologically-based PBPK modeling Novel Life Cycle management strategies for poorly soluble drugs Leading session topics and takeaways include: Breakthrough innovations in the next generation of drug products: A new thinking for formulation design Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies Beyond the pill: Addressing future patient needs through the importance of pharmaceutical profiling Effective formulation development strategies for improving oral bioavailability of poorly water-soluble drugs Characterization of amorphous materials to advance product development Spray-dried dispersion formulations in suspensions and solid dosage forms Combining In-Vivo animal models with physiologically-based PBPK modeling Why Attend? 20+ industry-led speaker faculty over 2 full days sharing innovative take-home strategies 100+ senior participants spanning pharma, biotech, regulatory and specialty delivery and formulation providers

2 5+ hours of networking and breakout sessions, including pre-conference meet up & evening cocktail reception Exhibit hall with leading formulation experts Speakers Esmaiel Jabbri, PhD. Professor of Chemical Engineering, University of South Carolina Abla Creasey, PhD. Associate Director- Therapeutics at California Institute for Regenerative Medicine Robert Prud'Homme, PhD. Professor and Director Program in Engr. Biology, Princeton University

3 Ilgaz Akseli, PhD., MBA Head of Formulation Profiling and Process Modeling, Boehringer Ingelheim Sudhakar Garad, PhD. Global Head of Chemical and Pharmaceutical Profiling, Novartis Varsha Biyyala, PhD. Senior Formulation Scientist, Oral Dosage Forms, Merck & Co.

4 Dhaval Patel, PhD. Senior Research Investigator, Bristol Myers Squibb Faraj Atassi, PhD. Principal Scientist, Chemical and Pharmaceutical Profiling, Novartis Wei Zhu, PhD. Associate Principal Scientist, Biopharmaceutics Pharmaceutical Sciences and Clinical Supply, Merck & Co.

5 John Morrison, PhD. Senior Research Investigator, Bristol Myers Squibb David Cipolla, PhD. Senior Director of Pharmaceutical Science, Aradigm Boris Shekunov, PhD. Senior Principal Scientist, Director, Analytical Technology, Global Pharmaceutical Technology, Shire Pharmaceuticals

6 René Holm, PhD. Head and Scientific Director, Liquids & Parenterals, The Janssen Pharmaceutical Companies of Johnson & Johnson Marian Gindy, PhD. Director, Parenteral Products Development, Merck & Co. David Schoneker, PhD. Director, Global Regulatory Affairs, Colorcon

7 Niya Bowers, PhD. Senior Program Officer at Bill & Melinda Gates Foundation Sudhakar Garad, PhD. Global Head of Chemical and Pharmaceutical Profiling, Novartis Please contact the event manager Marilyn ) below for: - Multiple participant discounts - Price quotations or visa invitation letters - Payment by alternate channels (PayPal, check, Western Union, wire transfers etc) - Event sponsorships NO REFUNDS ALLOWED ON REGISTRATIONS Service fees included in this listing Curtis & Coulter LLC. - New York Events List JOA190516CEV